128 related articles for article (PubMed ID: 20738794)
41. Pseudohypoparathyroidism type Ia. Albright hereditary osteodystrophy: a model for research on G protein-coupled receptors and genomic imprinting.
Simon A; Koppeschaar HP; Roijers JF; Höppener JW; Lips CJ
Neth J Med; 2000 Mar; 56(3):100-9. PubMed ID: 10759021
[TBL] [Abstract][Full Text] [Related]
42. [Paternal GNAS mutations: Which phenotypes? What genetic counseling?].
Kottler ML
Ann Endocrinol (Paris); 2015 May; 76(2):105-9. PubMed ID: 25952723
[TBL] [Abstract][Full Text] [Related]
43. A novel GNAS mutation in an infant boy with pseudohypoparathyroidism type Ia and normal serum calcium and phosphate levels.
Reis MT; Cattani A; Mendonca BB; Corrêa PH; Martin RM
Arq Bras Endocrinol Metabol; 2010 Nov; 54(8):728-31. PubMed ID: 21340160
[TBL] [Abstract][Full Text] [Related]
44. Cognitive impairment is prevalent in pseudohypoparathyroidism type Ia, but not in pseudopseudohypoparathyroidism: possible cerebral imprinting of Gsalpha.
Mouallem M; Shaharabany M; Weintrob N; Shalitin S; Nagelberg N; Shapira H; Zadik Z; Farfel Z
Clin Endocrinol (Oxf); 2008 Feb; 68(2):233-9. PubMed ID: 17803690
[TBL] [Abstract][Full Text] [Related]
45. Osteoma cutis as a presenting sign of pseudohypoparathyroidism.
Prendiville JS; Lucky AW; Mallory SB; Mughal Z; Mimouni F; Langman CB
Pediatr Dermatol; 1992 Mar; 9(1):11-8. PubMed ID: 1574470
[TBL] [Abstract][Full Text] [Related]
46. Images in clinical medicine. Albright's hereditary osteodystrophy.
Rolla AR; Rodriguez-Gutierrez R
N Engl J Med; 2012 Dec; 367(26):2527. PubMed ID: 23268667
[No Abstract] [Full Text] [Related]
47. Albright's hereditary osteodystrophy.
Wilson LC
J Pediatr Endocrinol Metab; 2006 May; 19 Suppl 2():671-3. PubMed ID: 16789633
[No Abstract] [Full Text] [Related]
48. Clinical review: Pseudohypoparathyroidism: diagnosis and treatment.
Mantovani G
J Clin Endocrinol Metab; 2011 Oct; 96(10):3020-30. PubMed ID: 21816789
[TBL] [Abstract][Full Text] [Related]
49. Albright hereditary osteodystrophy and del(2) (q37.3) in four unrelated individuals.
Phelan MC; Rogers RC; Clarkson KB; Bowyer FP; Levine MA; Estabrooks LL; Severson MC; Dobyns WB
Am J Med Genet; 1995 Jul; 58(1):1-7. PubMed ID: 7573148
[TBL] [Abstract][Full Text] [Related]
50. Determination of Gs alpha protein activity in Albright's hereditary osteodystrophy.
Ahrens W; Hiort O
J Pediatr Endocrinol Metab; 2006 May; 19 Suppl 2():647-51. PubMed ID: 16789630
[TBL] [Abstract][Full Text] [Related]
51. RDCI, the vasoactive intestinal peptide receptor: a candidate gene for the features of Albright hereditary osteodystrophy associated with deletion of 2q37.
Power MM; James RS; Barber JC; Fisher AM; Wood PJ; Leatherdale BA; Flanagan DE; Hatchwell E
J Med Genet; 1997 Apr; 34(4):287-90. PubMed ID: 9138150
[TBL] [Abstract][Full Text] [Related]
52. Germline mosaicism for a GNAS1 mutation and Albright hereditary osteodystrophy.
Aldred MA; Bagshaw RJ; Macdermot K; Casson D; Murch SH; Walker-Smith JA; Trembath RC
J Med Genet; 2000 Nov; 37(11):E35. PubMed ID: 11073544
[No Abstract] [Full Text] [Related]
53. Mutations of signal-transducing G proteins in human disease.
Schnabel P; Böhm M
J Mol Med (Berl); 1995 May; 73(5):221-8. PubMed ID: 7670925
[TBL] [Abstract][Full Text] [Related]
54. Gs(alpha) mutations and imprinting defects in human disease.
Weinstein LS; Chen M; Liu J
Ann N Y Acad Sci; 2002 Jun; 968():173-97. PubMed ID: 12119276
[TBL] [Abstract][Full Text] [Related]
55. Progressive osseous heteroplasia-like heterotopic ossification in a male infant with pseudohypoparathyroidism type Ia: a case report.
Gelfand IM; Hub RS; Shore EM; Kaplan FS; Dimeglio LA
Bone; 2007 May; 40(5):1425-8. PubMed ID: 17321228
[TBL] [Abstract][Full Text] [Related]
56. Three cases of osteoma cutis occurring in infancy. A brief overview of osteoma cutis and its association with pseudo-pseudohypoparathyroidism.
Ward S; Sugo E; Verge CF; Wargon O
Australas J Dermatol; 2011 May; 52(2):127-31. PubMed ID: 21605097
[TBL] [Abstract][Full Text] [Related]
57. [Type I pseudohypoparathyroidism. Study and prolonged follow-up of a case].
Pardos LC; Buñuel C; Antón R; García C; Lasarte JJ; Mayayo E; Ferrández A
An Esp Pediatr; 1989 Sep; 31(3):240-7. PubMed ID: 2631607
[TBL] [Abstract][Full Text] [Related]
58. Early-Onset Obesity: Unrecognized First Evidence for GNAS Mutations and Methylation Changes.
Grüters-Kieslich A; Reyes M; Sharma A; Demirci C; DeClue TJ; Lankes E; Tiosano D; Schnabel D; Jüppner H
J Clin Endocrinol Metab; 2017 Aug; 102(8):2670-2677. PubMed ID: 28453643
[TBL] [Abstract][Full Text] [Related]
59. Lessons from McCune-Albright syndrome-associated intraductal papillary mucinous neoplasms: : GNAS-activating mutations in pancreatic carcinogenesis.
Parvanescu A; Cros J; Ronot M; Hentic O; Grybek V; Couvelard A; Levy P; Chanson P; Ruszniewski P; Sauvanet A; Gaujoux S
JAMA Surg; 2014 Aug; 149(8):858-62. PubMed ID: 24898823
[TBL] [Abstract][Full Text] [Related]
60. Linear skin atrophy preceding calcinosis cutis in pseudo-pseudohypoparathyroidism.
Lau K; Willig RP; Hiort O; Hoeger PH
Clin Exp Dermatol; 2012 Aug; 37(6):646-8. PubMed ID: 22299648
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
